• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于社区的肺癌筛查结果与患者和放射科医生特征的关系:PROSPR 联盟。

Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.

机构信息

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado.

Center for Integrated Healthcare Research, Kaiser Permanente Hawaii, Oahu, Hawaii.

出版信息

Ann Am Thorac Soc. 2022 Mar;19(3):433-441. doi: 10.1513/AnnalsATS.202011-1413OC.

DOI:10.1513/AnnalsATS.202011-1413OC
PMID:34543590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8937226/
Abstract

Lung-RADS classification was developed to standardize reporting and management of lung cancer screening using low-dose computed tomographic (LDCT) imaging. Although variation in Lung-RADS distribution between healthcare systems has been reported, it is unclear if this is explained by patient characteristics, radiologist experience with lung cancer screening, or other factors. Our objective was to determine if patient or radiologist factors are associated with Lung-RADS score. In the Population-based Research to Optimize the Screening Process (PROSPR) Lung consortium, we conducted a study of patients who received their first screening LDCT imaging at one of the five healthcare systems in the PROSPR Lung Research Center from May 1, 2014, through December 31, 2017. Data on LDCT scans, patient factors, and radiologist characteristics were obtained via electronic health records. LDCT scan findings were categorized using Lung-RADS (negative [1], benign [2], probably benign [3], or suspicious [4]). We used generalized estimating equations with a multinomial distribution to compare the odds of Lung-RADS 3, and separately Lung-RADS 4, versus Lung-RADS 1 or 2 and estimated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between Lung-RADS assignment and patient and radiologist characteristics. Analyses included 8,556 patients; 24% were assigned Lung-RADS 1, 60% Lung-RADS 2, 10% Lung-RADS 3, and 5% Lung-RADS 4. Age was positively associated with Lung-RADS 3 (OR, 1.02; 95% CI, 1.01-1.03) and 4 (OR, 1.03; 95% CI, 1.01-1.05); chronic obstructive pulmonary disease (COPD) was positively associated with Lung-RADS 4 (OR, 1.78; 95% CI, 1.45-2.20); obesity was inversely associated with Lung-RADS 3 (OR, 0.70; 95% CI, 0.58-0.84) and 4 (OR, 0.58; 95% CI, 0.45-0.75). There was no association between sex, race, ethnicity, education, or smoking status and Lung-RADS assignment. Radiologist volume of interpreting screening LDCT scans, years in practice, and thoracic specialty were also not associated with Lung-RADS assignment. Healthcare systems that are comprised of patients with an older age distribution or higher levels of COPD will have a greater proportion of screening LDCT scans with Lung-RADS 3 or 4 findings and should plan for additional resources to support appropriate and timely management of noted positive findings.

摘要

肺结节放射学报告和数据系统(Lung-RADS)分类旨在规范使用低剂量计算机断层扫描(LDCT)进行肺癌筛查的报告和管理。尽管已经报道了不同医疗系统之间 Lung-RADS 分布的差异,但尚不清楚这是由患者特征、放射科医生的肺癌筛查经验还是其他因素导致的。我们的目的是确定患者或放射科医生的因素是否与 Lung-RADS 评分相关。在基于人群的优化筛查过程研究(PROSPR)肺部研究中心的五个医疗系统中,我们对 2014 年 5 月 1 日至 2017 年 12 月 31 日期间接受首次筛查 LDCT 成像的患者进行了一项研究。通过电子健康记录获得 LDCT 扫描、患者特征和放射科医生特征的数据。使用 Lung-RADS(阴性[1]、良性[2]、可能良性[3]或可疑[4])对 LDCT 扫描结果进行分类。我们使用具有多项分布的广义估计方程来比较 Lung-RADS 3 和单独的 Lung-RADS 4 与 Lung-RADS 1 或 2 的比值比(OR),并估计 Lung-RADS 分配与患者和放射科医生特征之间的关联的调整 OR 和 95%置信区间(CI)。分析包括 8556 名患者;24%被分配 Lung-RADS 1,60% Lung-RADS 2,10% Lung-RADS 3,5% Lung-RADS 4。年龄与 Lung-RADS 3(OR,1.02;95%CI,1.01-1.03)和 4(OR,1.03;95%CI,1.01-1.05)呈正相关;慢性阻塞性肺疾病(COPD)与 Lung-RADS 4 呈正相关(OR,1.78;95%CI,1.45-2.20);肥胖与 Lung-RADS 3(OR,0.70;95%CI,0.58-0.84)和 4(OR,0.58;95%CI,0.45-0.75)呈负相关。性别、种族、民族、教育程度或吸烟状况与 Lung-RADS 分配无关。放射科医生解读筛查 LDCT 扫描的数量、从业年限和胸部专业也与 Lung-RADS 分配无关。由年龄分布较大或 COPD 水平较高的患者组成的医疗系统将有更大比例的筛查 LDCT 扫描结果为 Lung-RADS 3 或 4,并且需要计划额外的资源来支持对发现的阳性结果进行适当和及时的管理。

相似文献

1
Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.基于社区的肺癌筛查结果与患者和放射科医生特征的关系:PROSPR 联盟。
Ann Am Thorac Soc. 2022 Mar;19(3):433-441. doi: 10.1513/AnnalsATS.202011-1413OC.
2
Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.密西西比三角洲地区接受肺癌筛查或符合指南的肺结节监测人群的肺癌风险评估。
JAMA Netw Open. 2023 Feb 1;6(2):e230787. doi: 10.1001/jamanetworkopen.2023.0787.
3
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.国家肺癌筛查试验中Lung-RADS的表现:一项回顾性评估
Ann Intern Med. 2015 Apr 7;162(7):485-91. doi: 10.7326/M14-2086.
4
Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.肺癌筛查的 MRI 检查:通过比较前两轮筛查中 LDCT 和 MRI 衍生的 Lung-RADS 分类,对肺癌筛查的 MRI 检查进行评估。
Eur Radiol. 2019 Feb;29(2):898-905. doi: 10.1007/s00330-018-5607-8. Epub 2018 Jul 10.
5
Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.肺结节体积在 Lung-RADS v1.1 中的肺癌筛查:阴性基线 CT 可能增加筛查间隔。
Eur Radiol. 2021 Apr;31(4):1956-1968. doi: 10.1007/s00330-020-07275-w. Epub 2020 Sep 30.
6
Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium.在PROSPR-肺癌联盟中,经医疗服务提供者开具筛查医嘱后肺癌筛查CT的接受情况。
J Gen Intern Med. 2024 Feb;39(2):186-194. doi: 10.1007/s11606-023-08408-9. Epub 2023 Oct 2.
7
Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3).在中国肺癌筛查计划(Nelcin-B3)中,低剂量 CT 扫描中的视觉肺气肿与肺结节之间的关联。
Eur Radiol. 2022 Dec;32(12):8162-8170. doi: 10.1007/s00330-022-08884-3. Epub 2022 Jun 9.
8
Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.与多个筛查时间点的肺癌筛查不依从相关的因素。
JAMA Netw Open. 2023 May 1;6(5):e2315250. doi: 10.1001/jamanetworkopen.2023.15250.
9
Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.超过 100 万人接受低剂量 CT 成像筛查肺癌的结果。
Chest. 2023 Jul;164(1):241-251. doi: 10.1016/j.chest.2023.02.003. Epub 2023 Feb 10.
10
Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.真实世界肺癌CT筛查表现、吸烟行为及对建议的依从性:Lung-RADS分类和吸烟状况可预测依从性。
AJR Am J Roentgenol. 2021 Apr;216(4):919-926. doi: 10.2214/AJR.20.23637. Epub 2021 Feb 17.

引用本文的文献

1
The United States' Early Experience With Lung Cancer Screening-Creation of a National Data Linkage: A Brief Report.美国肺癌筛查的早期经验——建立国家数据关联:简要报告
JTO Clin Res Rep. 2025 Mar 20;6(6):100825. doi: 10.1016/j.jtocrr.2025.100825. eCollection 2025 Jun.
2
Multimodal Framework in Lung Cancer Management: Integrating Liquid Biopsy with Traditional Diagnostic Techniques.肺癌管理中的多模态框架:将液体活检与传统诊断技术相结合。
Cancer Manag Res. 2025 Mar 3;17:461-481. doi: 10.2147/CMAR.S506630. eCollection 2025.
3
Patterns of recurrence among adults diagnosed with screen-detected lung cancer.经筛查发现的肺癌成年患者的复发模式。
Cancer Epidemiol. 2025 Apr;95:102777. doi: 10.1016/j.canep.2025.102777. Epub 2025 Feb 18.
4
Association of systemic therapy with survival among adults with advanced non-small cell lung cancer.全身治疗与晚期非小细胞肺癌成年患者生存率的关联
Transl Lung Cancer Res. 2025 Jan 24;14(1):176-193. doi: 10.21037/tlcr-24-749. Epub 2025 Jan 22.
5
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.在常规临床实践中与肺癌筛查相关的下游程序和并发症的发生率:一项回顾性队列研究。
Ann Intern Med. 2024 Jan;177(1):18-28. doi: 10.7326/M23-0653. Epub 2024 Jan 2.
6
Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer.新型全身治疗药物的应用:晚期非小细胞肺癌成人患者的真实世界模式。
Cancer Treat Res Commun. 2023;36:100730. doi: 10.1016/j.ctarc.2023.100730. Epub 2023 Jun 14.
7
Smoking status and the association between patient-level factors and survival among lung cancer patients.吸烟状况与肺癌患者个体因素与生存的相关性。
J Natl Cancer Inst. 2023 Aug 8;115(8):937-948. doi: 10.1093/jnci/djad098.
8
Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.低剂量计算机断层扫描筛查对肺癌发病率和结局的影响。
Curr Opin Pulm Med. 2023 Jul 1;29(4):232-238. doi: 10.1097/MCP.0000000000000974. Epub 2023 May 16.
9
Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening.启动低剂量 CT 筛查后肺癌发病率的阶段迁移。
J Thorac Oncol. 2022 Dec;17(12):1355-1364. doi: 10.1016/j.jtho.2022.08.011. Epub 2022 Sep 7.
10
Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3).在中国肺癌筛查计划(Nelcin-B3)中,低剂量 CT 扫描中的视觉肺气肿与肺结节之间的关联。
Eur Radiol. 2022 Dec;32(12):8162-8170. doi: 10.1007/s00330-022-08884-3. Epub 2022 Jun 9.

本文引用的文献

1
Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.肺 CT 筛查报告和数据系统在亚实性结节富集型肺癌筛查 CT 中的分类中观察者间的变异性。
Eur Radiol. 2021 Sep;31(9):7184-7191. doi: 10.1007/s00330-021-07800-5. Epub 2021 Mar 17.
2
Lung cancer screening in Appalachian Kentucky: The impact of Lung-RADS on subsequent testing and cancer identification.肯塔基州阿巴拉契亚地区的肺癌筛查:Lung-RADS对后续检查及癌症识别的影响。
J Clin Transl Sci. 2019 Sep 12;4(5):468-471. doi: 10.1017/cts.2019.416.
3
Variability in interpretation of low-dose chest CT using computerized assessment in a nationwide lung cancer screening program: comparison of prospective reading at individual institutions and retrospective central reading.在全国性肺癌筛查计划中,使用计算机评估对低剂量胸部 CT 的解读存在变异性:个体机构前瞻性阅读与回顾性中心阅读的比较。
Eur Radiol. 2021 May;31(5):2845-2855. doi: 10.1007/s00330-020-07424-1. Epub 2020 Oct 30.
4
Rates of positive lung cancer screening examinations in academic versus community practice.学术机构与社区医疗机构中肺癌筛查阳性率的比较。
Transl Lung Cancer Res. 2020 Aug;9(4):1528-1532. doi: 10.21037/tlcr-19-673.
5
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
6
Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.肺癌筛查的真实世界临床实施——评估改善筛查指南一致性的流程
J Gen Intern Med. 2020 Apr;35(4):1143-1152. doi: 10.1007/s11606-019-05539-w. Epub 2020 Jan 23.
7
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.评估不同医疗体系中的肺癌筛查:来自 Lung PROSPR 联盟的过程模型。
Cancer Prev Res (Phila). 2020 Feb;13(2):129-136. doi: 10.1158/1940-6207.CAPR-19-0378. Epub 2019 Dec 23.
8
Lung cancer screening with submillisievert chest CT: Potential pitfalls of pulmonary findings in different readers with various experience levels.低剂量胸部 CT 筛查肺癌:不同经验水平的不同读者对肺部发现的潜在陷阱。
Eur J Radiol. 2019 Dec;121:108720. doi: 10.1016/j.ejrad.2019.108720. Epub 2019 Oct 25.
9
Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening.肺癌筛查中假阳性率的提高和对非预期伤害的高估。
Lung. 2019 Jun;197(3):327-332. doi: 10.1007/s00408-019-00217-4. Epub 2019 Apr 12.
10
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.MILD 试验证实:延长肺癌筛查时间可降低 10 年死亡率,再次确认肺癌筛查的有效性。
Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117.